Asia-Pacific Hypertrophic and Keloid Scar Treatment Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Scar Type (Hypertrophic and Keloid), Product Type (Laser Products, Topical Products, Injectables, and Other Products), and End User (Hospitals, Clinics, and Homecare)

TIPRE00025195 | Pages: 102 | Medical Device | Oct 2021 | Type: Regional | Status: Published

Market Introduction

The Asia-Pacific includes countries, including China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. The region is the fastest-growing in the global hypertrophic and keloid scar treatment market. The market's growth is attributed to increasing hypertrophic and keloid scar treatment in countries such as China, Japan, and India. In comparison, countries such as Australia and South Korea are expected to offer vital growth opportunities due to increased research related to hypertrophic and keloid scars. The overall market's growth is driven by scar treatment developments, growing injuries, and development in the healthcare system that has adopted newer techniques to treat different types of scars. China is expected to be the fastest contributor to the growth of hypertrophic and keloid scar treatment. Chinese people serve great demand for scar treatment as burn, trauma, and plastic surgery are more. In January 2015, a consensus panel was established for treating the scars caused by burn/trauma, plastic surgery, and dermatological conditions. On the other hand, topical medicines are widely preferred in the country. The Chinese Herb Medicine published a research article in December 2020 for anti-hypertrophic scar ointment. The ointment is six-herb Chinese medicine composition (SCMC). It is expected to improve the blood circulation condition of hypertrophic scar tissues. Thus, it is likely to a promising treatment for the hypertrophic and keloid scar treatment. Therefore, owing to scar treatment and topical products, the market is expected to grow at a faster rate.

 

Asia-Pacific countries are expecting to witness a huge challenge due to the increasing prevalence of COVID-19. Due to the outbreak of disease, healthcare industries have been affected badly, considering the economic conditions in the current situation. Due to the increasing COVID-19 cases, the cost for many treatments has been lowered. Considering the economic operations and geographic condition, the outbreak of the disease has affected medical tourism, manufacturers of medical equipment, laser systems, accessories, and other problems posed by the shortage of healthcare infrastructure in Asia-Pacific low-income countries. After the first case in December 2019 in Wuhan, China, the COVID-19 has spread to at least 180 countries and regions. To prevent the spread of disease, restrictive measures have been taken in countries such as India, South Korea, Singapore, Malaysia, and the Philippines. According to the World Health Organization (WHO), due to the rapidly changing risk of COVID-19 affected countries and constantly controlling outbreak trends, any additional health measures are likely to interfere with international travel and trade significantly. Countries such as Japan and Australia are conducting virtual international conferences to anticipate the impact of COVID-19 on the cosmetic industry in the Asia Pacific. The ongoing COVID-19 pandemic has created a seismic shift in living and cosmetic habits in the region, and hypertrophic and keloid scar treatment has borne a significant brunt of this shopper shake-up. China is explicitly facing issues with the pandemic, leading to disruption of the supply chain and projected losses in revenue, marketing, and sales within all industries—especially the hypertrophic and keloid scar treatment—and the concerns of health within the production units and other public places.


Get more information on this report :



Market Overview and Dynamics

The hypertrophic and keloid scar treatment market in Asia-Pacific is expected to grow from US$ 1,173.23 million in 2020 to US$ 2,455.28 million by 2027; it is estimated to grow at a CAGR of 11.1% from 2020 to 2027. Rising cases of injuries; injuries and their extension deep into the dermis are the major cause of hypertrophic and keloids scars. Injuries can be further classified as scratches, burns, cuts, gashes, sutures, surgical incisions, and so on. The prevalence rate of injuries ultimately converting to a keloid or hypertrophic scars is 5–15%. In addition, skin conditions such as acne and dark pigmentation also lead to hypertrophic and keloid scar development. The cases of different types of injuries are commonly seen among all age groups. Acne, sports injuries, and road accidents are more common among youngsters. Acne is also a common problem among middle-aged people, irrespective of their gender. The hormonal imbalance among people leads to acne, which might leave severe scars on skin. Acne is estimated to be affecting ~10% of the total global population. According to the WHO data published in February 2020, road accident-led injuries are the leading cause of death among young adults aged 5–29. ~1.35 million fatalities are registered per year due to road accidents. However, the rate of severe injuries by road accidents is also rising. Therefore, the increasing number of accidents is indirectly leading to the rising demand for hypertrophic and keloid scar treatments. This is bolstering the growth of the hypertrophic and keloid scar treatment market.

Key Market Segments

Based on scar type, the hypertrophic and keloid scar treatment market is segmented into hypertrophic and keloid. The hypertrophic segment held the largest share of the market in 2019. Based on product type, the hypertrophic and keloid scar treatment market is segmented into laser products, topical products, injectables, and other products. The injectables segment held the largest share of the market in 2019. Based on end user, the hypertrophic and keloid scar treatment market is segmented into hospitals, clinics, and homecare. The hospitals segment held the largest share of the market in 2019.

Major Sources and Companies Listed

A few major primary and secondary sources referred to for preparing this report on the hypertrophic and keloid scar treatment market in Asia-Pacific are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are Alliance Pharma PLC, Mölnlycke Health Care AB., Smith & Nephew, Newmedical Technology Inc., Lumenis, Sonoma Pharmaceuticals, Inc, Suneva Medical, HRA Pharma and Perrigo Company plc among others.

Reasons to buy report

  • To understand the Asia-Pacific hypertrophic and keloid scar treatment market landscape and identify market segments that are most likely to guarantee a strong return
  • Stay ahead of the race by comprehending the ever-changing competitive landscape for Asia-Pacific hypertrophic and keloid scar treatment market
  • Efficiently plan M&A and partnership deals in Asia-Pacific hypertrophic and keloid scar treatment market by identifying market segments with the most promising probable sales
  • Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form Asia-Pacific hypertrophic and keloid scar treatment market
  • Obtain market revenue forecast for market by various segments from 2020-2027 in Asia-Pacific region.

ASIA-PACIFIC HYPERTROPHIC AND KELOID SCAR TREATMENT MARKET SEGMENTATION

By Scar Type

  • Hypertrophic
  • Keloid

By Product Type

  • Injectables
  • Topical
    • Gels
    • Silicone Sheets
    • Creams
    • Other
  • Laser
    • CO2
    • Pulse-Dyed
    • Other
  • Other

By End User

  • Hospitals
  • Clinics
  • Homecare

 

By Country

  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia-Pacific

 

Company Profiles

  • Alliance Pharma PLC
  • HRA Pharma
  • Mölnlycke Health Care AB.
  • Newmedical Technology Inc.
  • Perrigo Company plc
  • Lumenis
  • Smith & Nephew
  • Sonoma Pharmaceuticals, Inc
  • Suneva Medical
 

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Asia-Pacific Hypertrophic and Keloid Scar Treatment Market – By Scar Type

1.3.2        Asia-Pacific Hypertrophic and Keloid Scar Treatment Market – By Product Type

1.3.3        Asia-Pacific Hypertrophic and Keloid Scar Treatment Market – By End User

1.3.4        Asia-Pacific Hypertrophic and Keloid Scar Treatment Market – By Country

2.           Asia-Pacific Hypertrophic and Keloid Scar Treatment Market – Key Takeaways

3.           Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Asia-Pacific Hypertrophic and Keloid Scar Treatment Market – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        Asia Pacific– PEST Analysis

4.3         Expert Opinion

5.           Asia-Pacific Hypertrophic and Keloid Scar Treatment Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Advantages of Laser Treatment

5.1.2        Rising Cases of Injuries

5.2         Market Restraints

5.2.1        Unavailability of Universal Treatment Due to High Costs, Side Effects, and Scanty Awareness

5.3         Market Opportunities

5.3.1        Tapping Market in Emerging Countries

5.4         Future Trends

5.4.1        Emerging Treatments Modalities

5.5         Impact Analysis

6.           Hypertrophic and Keloid Scar Treatment Market –  Asia-Pacific Analysis

6.1         Asia-Pacific Hypertrophic and Keloid Scar Treatment Market Revenue Forecast And Analysis

7.           Asia-Pacific Hypertrophic and Keloid Scar Treatment Market– By Scar Type

7.1         Overview

7.2         Asia-Pacific Hypertrophic and Keloid Scar Treatment Market Share, by Scar Type, 2019 and 2027 (%)

7.3         Hypertrophic

7.3.1        Overview

7.3.2        Hypertrophic: Asia-Pacific Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

7.4         Keloid

7.4.1        Overview

7.4.2        Keloid: Asia-Pacific Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

8.           Asia-Pacific Hypertrophic and Keloid Scar Treatment Market– By Product Type

8.1         Overview

8.2         Asia-Pacific Hypertrophic and Keloid Scar Treatment Market Share, by Product Type, 2019 and 2027 (%)

8.3         Laser Products

8.3.1        Overview

8.3.2        Laser Products: Asia-Pacific Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

8.3.2.1          CO2 Market

8.3.2.1.1          Overview

8.3.2.1.2          CO2 Market: Asia-Pacific Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

8.3.2.2          Pulse-Dyed Market

8.3.2.2.1          Overview

8.3.2.2.2          Pulse-Dyed Market: Asia-Pacific Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

8.3.2.3          Other Laser Products Market

8.3.2.3.1          Overview

8.3.2.3.2          Other Laser Products: Asia-Pacific Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

8.4         Topical Products

8.4.1        Overview

8.4.2        Topical Products: Asia-Pacific Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

8.4.2.1          Creams Market

8.4.2.1.1          Overview

8.4.2.1.2          Creams: Asia-Pacific Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

8.4.2.2          Gels Market

8.4.2.2.1          Overview

8.4.2.2.2          Gels: Asia-Pacific Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

8.4.2.3          Silicone Sheets Market

8.4.2.3.1          Overview

8.4.2.3.2          Silicone Sheets: Asia-Pacific Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

8.4.2.4          Other Topical Products Market

8.4.2.4.1          Overview

8.4.2.4.2          Others Topical Products: Asia-Pacific Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

8.5         Injectables

8.5.1        Overview

8.5.2        Injectables: Asia-Pacific Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

8.6         Other Products

8.6.1        Overview

8.6.2        Other Products: Asia-Pacific Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

9.           Asia-Pacific Hypertrophic and Keloid Scar Treatment Market– By End User

9.1         Overview

9.2         Asia-Pacific Hypertrophic and Keloid Scar Treatment Market Share, by End User, 2019 and 2027 (%)

9.3         Hospitals

9.3.1        Overview

9.3.2        Hospitals: Asia-Pacific Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

9.4         Clinics

9.4.1        Overview

9.4.2        Clinics: Asia-Pacific Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

9.5         Homecare

9.5.1        Overview

9.5.2        Homecare: Asia-Pacific Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

10.        Asia-Pacific Hypertrophic and Keloid Scar Treatment Market – Country Analysis

10.1      Asia Pacific: Hypertrophic and Keloid Scar Treatment Market

10.1.1     Overview

10.1.2     Asia Pacific: Hypertrophic and Keloid Scar Treatment Market, by Country, 2019 & 2027 (%)

10.1.3     Japan: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)

10.1.3.1       Japan: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)

10.1.3.2       Japan: Hypertrophic and Keloid Scar Treatment Market, by Scar Type, 2018–2027 (USD Million)

10.1.3.3       Japan: Hypertrophic and Keloid Scar Treatment Market, by Product Type, 2018–2027 (USD Million)

10.1.3.3.1       Japan: Laser Products Market, by Type, 2018–2027 (USD Million)

10.1.3.3.2       Japan: Topical Products Market, by Type, 2018–2027 (USD Million)

10.1.3.4       Japan: Hypertrophic and Keloid Scar Treatment Market, by End User, 2018–2027 (USD Million)

10.1.4     China: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)

10.1.4.1       China: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)

10.1.4.2       China: Hypertrophic and Keloid Scar Treatment Market, by Scar Type, 2018–2027 (USD Million)

10.1.4.3       China: Hypertrophic and Keloid Scar Treatment Market, by Product Type, 2018–2027 (USD Million)

10.1.4.3.1       China: Laser Products Market, by Type, 2018–2027 (USD Million)

10.1.4.3.2       China: Topical Products Market, by Type, 2018–2027 (USD Million)

10.1.4.4       China: Hypertrophic and Keloid Scar Treatment Market, by End User, 2018–2027 (USD Million)

10.1.5     India: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)

10.1.5.1       India: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)

10.1.5.2       India: Hypertrophic and Keloid Scar Treatment Market, by Scar Type, 2018–2027 (USD Million)

10.1.5.3       India: Hypertrophic and Keloid Scar Treatment Market, by Product Type, 2018–2027 (USD Million)

10.1.5.3.1       India: Laser Products Market, by Type, 2018–2027 (USD Million)

10.1.5.3.2       India: Topical Products Market, by Type, 2018–2027 (USD Million)

10.1.5.4       India: Hypertrophic and Keloid Scar Treatment Market, by End User, 2018–2027 (USD Million)

10.1.6     South Korea: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)

10.1.6.1       South Korea: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)

10.1.6.2       South Korea: Hypertrophic and Keloid Scar Treatment Market, by Scar Type, 2018–2027 (USD Million)

10.1.6.3       South Korea: Hypertrophic and Keloid Scar Treatment Market, by Product Type, 2018–2027 (USD Million)

10.1.6.3.1       South Korea: Laser Products Market, by Type, 2018–2027 (USD Million)

10.1.6.3.2       South Korea: Topical Products Market, by Type, 2018–2027 (USD Million)

10.1.6.4       South Korea: Hypertrophic and Keloid Scar Treatment Market, by End User, 2018–2027 (USD Million)

10.1.7     Australia: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)

10.1.7.1       Australia: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)

10.1.7.2       Australia: Hypertrophic and Keloid Scar Treatment Market, by Scar Type, 2018–2027 (USD Million)

10.1.7.3       Australia: Hypertrophic and Keloid Scar Treatment Market, by Product Type, 2018–2027 (USD Million)

10.1.7.3.1       Australia: Laser Products Market, by Type, 2018–2027 (USD Million)

10.1.7.3.2       Australia: Topical Products Market, by Type, 2018–2027 (USD Million)

10.1.7.4       Australia: Hypertrophic and Keloid Scar Treatment Market, by End User, 2018–2027 (USD Million)

10.1.8     Rest of Asia Pacific: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)

10.1.8.1       Rest of Asia Pacific: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)

10.1.8.2       Rest of Asia Pacific: Hypertrophic and Keloid Scar Treatment Market, by Scar Type, 2018–2027 (USD Million)

10.1.8.3       Rest of Asia Pacific: Hypertrophic and Keloid Scar Treatment Market, by Product Type, 2018–2027 (USD Million)

10.1.8.3.1       Rest of Asia Pacific: Laser Products Market, by Type, 2018–2027 (USD Million)

10.1.8.3.2       Rest of Asia Pacific: Topical Products Market, by Type, 2018–2027 (USD Million)

10.1.8.4       Rest of Asia Pacific: Hypertrophic and Keloid Scar Treatment Market, by End User, 2018–2027 (USD Million)

11.        Impact Of COVID-19 Pandemic On Asia-Pacific Hypertrophic and Keloid Scar Treatment Market

11.1      Asia-Pacific: Impact Assessment of COVID-19 Pandemic

12.        Asia-Pacific Hypertrophic and Keloid Scar Treatment Market–Industry Landscape

12.2      Organic Developments

12.2.1     Overview

12.3      Inorganic Developments

12.3.1     Overview

13.        COMPANY PROFILES

13.1      Alliance Pharma PLC

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2      Mölnlycke Health Care AB.

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3      Smith & Nephew

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4      Newmedical Technology Inc.

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5      Sonoma Pharmaceuticals, Inc.

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6      Suneva Medical

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7      HRA Pharma

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

13.8      Lumenis

13.8.1     Key Facts

13.8.2     Business Description

13.8.3     Products and Services

13.8.4     Financial Overview

13.8.5     SWOT Analysis

13.8.6     Key Developments

13.9      Perrigo Company plc

13.9.1     Key Facts

13.9.2     Business Description

13.9.3     Products and Services

13.9.4     Financial Overview

13.9.5     SWOT Analysis

13.9.6     Key Developments

14.        Appendix

14.1      About The Insight Partners

14.2      Glossary of Terms

LIST OF TABLES

Table 1.             Asia-Pacific Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (US$ Million)

Table 2.             Japan: Hypertrophic and Keloid Scar Treatment Market, by Scar Type – Revenue and Forecast to 2027 (USD Million)

Table 3.             Japan: Hypertrophic and Keloid Scar Treatment Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

Table 4.             Japan: Laser Products Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 5.             Japan: Topical Products Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 6.             Japan: Hypertrophic and Keloid Scar Treatment Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 7.             China: Hypertrophic and Keloid Scar Treatment Market, by Scar Type – Revenue and Forecast to 2027 (USD Million)

Table 8.             China: Hypertrophic and Keloid Scar Treatment Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

Table 9.             China: Laser Products Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 10.          China: Topical Products Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 11.          China: Hypertrophic and Keloid Scar Treatment Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 12.          India: Hypertrophic and Keloid Scar Treatment Market, by Scar Type – Revenue and Forecast to 2027 (USD Million)

Table 13.          India: Hypertrophic and Keloid Scar Treatment Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

Table 14.          India: Laser Products Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 15.          India: Topical Products Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 16.          India: Hypertrophic and Keloid Scar Treatment Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 17.          South Korea: Hypertrophic and Keloid Scar Treatment Market, by Scar Type – Revenue and Forecast to 2027 (USD Million)

Table 18.          South Korea: Hypertrophic and Keloid Scar Treatment Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

Table 19.          South Korea: Laser Products Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 20.          South Korea: Topical Products Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 21.          South Korea: Hypertrophic and Keloid Scar Treatment Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 22.          Australia: Hypertrophic and Keloid Scar Treatment Market, by Scar Type – Revenue and Forecast to 2027 (USD Million)

Table 23.          Australia: Hypertrophic and Keloid Scar Treatment Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

Table 24.          Australia: Laser Products Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 25.          Australia: Topical Products Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 26.          Australia: Hypertrophic and Keloid Scar Treatment Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 27.          Rest of Asia Pacific: Hypertrophic and Keloid Scar Treatment Market, by Scar Type – Revenue and Forecast to 2027 (USD Million)

Table 28.          Rest of Asia Pacific: Hypertrophic and Keloid Scar Treatment Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

Table 29.          Rest of Asia Pacific: Laser Products Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 30.          Rest of Asia Pacific: Topical Products Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 31.          Rest of Asia Pacific: Hypertrophic and Keloid Scar Treatment Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 32.          Organic Developments Done By Companies

Table 33.          Inorganic Developments Done By Companies

Table 34.          Glossary of Terms, Hypertrophic and Keloid Scar Treatment Market

LIST OF FIGURES

Figure 1.           Asia-Pacific Hypertrophic and Keloid Scar Treatment Market Segmentation

Figure 2.           Asia-Pacific Hypertrophic and Keloid Scar Treatment Market, By Country

Figure 3.           Asia-Pacific Hypertrophic and Keloid Scar Treatment Market Overview

Figure 4.           Hypertrophic Segment Held Largest Share of Scar Type Segment In Asia-Pacific Hypertrophic and Keloid Scar Treatment Market

Figure 5.           China Is Expected to Show Remarkable Growth During the Forecast Period

Figure 6.           Asia-Pacific PEST Analysis

Figure 7.           Expert Opinion

Figure 8.           Asia-Pacific Hypertrophic and Keloid Scar Treatment Market Impact Analysis of Drivers and Restraint

Figure 9.           Asia-Pacific Hypertrophic and Keloid Scar Treatment Market – Revenue Forecast and Analysis – 2019- 2027

Figure 10.        Asia-Pacific Hypertrophic and Keloid Scar Treatment Market Share, by Scar Type, 2019 and 2027 (%)

Figure 11.        Hypertrophic: Asia-Pacific Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

Figure 12.        Keloid: Asia-Pacific Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

Figure 13.        Asia-Pacific Hypertrophic and Keloid Scar Treatment Market Share, by Product Type, 2019 and 2027 (%)

Figure 14.        Laser Products: Asia-Pacific Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

Figure 15.        CO2 Market: Asia-Pacific Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

Figure 16.        Pulse-Dyed Market: Asia-Pacific Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

Figure 17.        Other Laser Products Market: Asia-Pacific Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

Figure 18.        Topical Products: Asia-Pacific Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

Figure 19.        Creams Market: Asia-Pacific Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

Figure 20.        Gels Market: Asia-Pacific Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

Figure 21.        Silicone Sheets Market: Asia-Pacific Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

Figure 22.        Other Topical Products Market: Asia-Pacific Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

Figure 23.        Injectables: Asia-Pacific Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

Figure 24.        Other Products: Asia-Pacific Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

Figure 25.        Asia-Pacific Hypertrophic and Keloid Scar Treatment Market Share, by End User, 2019 and 2027 (%)

Figure 26.        Hospitals: Asia-Pacific Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

Figure 27.        Clinics: Asia-Pacific Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

Figure 28.        Homecare: Asia-Pacific Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

Figure 29.        Asia Pacific: Hypertrophic and Keloid Scar Treatment Market, by Key Country – Revenue (2019) (USD Million)

Figure 30.        Asia Pacific: Hypertrophic and Keloid Scar Treatment Market, by Country, 2019 & 2027 (%)

Figure 31.        Japan: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)

Figure 32.        China: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)

Figure 33.        India: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)

Figure 34.        South Korea: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)

Figure 35.        Australia: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)

Figure 36.        Rest of Asia Pacific: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)

Figure 37.        Impact of COVID-19 Pandemic in Asia-Pacific Country Markets

  1. Alliance Pharma PLC
  2. HRA Pharma
  3. Mölnlycke Health Care AB.
  4. Newmedical Technology Inc.
  5. Perrigo Company plc
  6. Lumenis
  7. Smith & Nephew
  8. Sonoma Pharmaceuticals, Inc
  9. Suneva Medical
  • To understand the Asia-Pacific hypertrophic and keloid scar treatment market landscape and identify market segments that are most likely to guarantee a strong return
  • Stay ahead of the race by comprehending the ever-changing competitive landscape for Asia-Pacific hypertrophic and keloid scar treatment market
  • Efficiently plan M&A and partnership deals in Asia-Pacific hypertrophic and keloid scar treatment market by identifying market segments with the most promising probable sales
  • Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form Asia-Pacific hypertrophic and keloid scar treatment market
  • Obtain market revenue forecast for market by various segments from 2020-2027 in Asia-Pacific region.
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3000
$1800
Site License
$4000
$2400
Enterprise License
$5000
$3000